Priority review granted by the FDA for TTNP's 6 month implant to treat drug addiction.
Millions are hooked on pain meds and illicit drugs.
Approval on April 30 will earn TTNP a $50 million milestone plus hefty double digit royalties.
TTNP is also advancing its ProNeura technology for chronic pain and Parkinson's.